Arthur Weinstein

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 7

Top Topics

Systemic Lupus Erythematosus

Disease Activity

Combination Therapy

Top Venues

Arthritis & rheumatology (Hoboken, N.J.)

ACR open rheumatology

Current rheumatology reports

Arthritis care & research

This page only lists publications with an associated author ORCID identifier.

Publications

Arthur Weinstein, Roberta V Alexander, Debra J Zack
A Review of Complement Activation in SLE. Current rheumatology reports 23 (3) (2021)
Rosalind Ramsey-Goldman, Roberta Vezza Alexander, John Conklin, Cristina Arriens, Sonali Narain, Elena M Massarotti, Daniel J Wallace, Christopher E Collins, Amit Saxena, Chaim Putterman, Kelley Brady, Kenneth C Kalunian, Arthur Weinstein
A Multianalyte Assay Panel With Cell-Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology-Classified Lupus. ACR open rheumatology 3 (2) (2021)
Ann Elaine Clarke, Arthur Weinstein, Andrew Piscitello, Avneet Heer, Tarun Chandra, Shivang Doshi, John Wegener, Thomas F Goss, Tami Powell
Evaluation of the Economic Benefit of Earlier Systemic Lupus Erythematosus (SLE) Diagnosis Using a Multivariate Assay Panel (MAP). ACR open rheumatology 2 (11) (2020)
Arthur Weinstein
Cell-Bound Complement Activation Products Are Superior to Serum Complement C3 and C4 Levels to Detect Complement Activation in Systemic Lupus Erythematosus: Comment on the Article by Aringer et al. Arthritis & rheumatology (Hoboken, N.J.) 72 (5) (2020)
Roberta Vezza Alexander, Arthur Weinstein
A Combination of Complement Activation Products With Autoantibodies Predicts Transition of Probable Lupus to Systemic Lupus Erythematosus: Comment on the Article by Lambers et al. Arthritis care & research 72 (12) (2020)
Daniel J Wallace, Ellen M Ginzler, Joan T Merrill, Richard A Furie, William Stohl, W Winn Chatham, Arthur Weinstein, James D McKay, W Joseph McCune, Michelle A Petri, James Fettiplace, David A Roth, Beulah N Ji, Amy Heath
Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus. Arthritis & rheumatology (Hoboken, N.J.) 71 (7) (2019)
Rosalind Ramsey-Goldman, Roberta Vezza Alexander, Elena M Massarotti, Daniel J Wallace, Sonali Narain, Cristina Arriens, Christopher E Collins, Amit Saxena, Chaim Putterman, Kenneth C Kalunian, Tyler O'Malley, Thierry Dervieux, Arthur Weinstein
Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus. Arthritis & rheumatology (Hoboken, N.J.) 72 (1) (2019)